These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23581476)

  • 21. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
    Dost R; Rostock A; Rundfeldt C
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):382-90. PubMed ID: 15007538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retigabine holds KV7 channels open and stabilizes the resting potential.
    Corbin-Leftwich A; Mossadeq SM; Ha J; Ruchala I; Le AH; Villalba-Galea CA
    J Gen Physiol; 2016 Mar; 147(3):229-41. PubMed ID: 26880756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.
    Gunthorpe MJ; Large CH; Sankar R
    Epilepsia; 2012 Mar; 53(3):412-24. PubMed ID: 22220513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy.
    Zhang F; Liu Y; Tang F; Liang B; Chen H; Zhang H; Wang K
    FASEB J; 2019 Aug; 33(8):9154-9166. PubMed ID: 31063701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional haemodynamic effects of human and rat adrenomedullin in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1995 Feb; 114(3):584-91. PubMed ID: 7735684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Bennett T
    Br J Pharmacol; 1996 May; 118(2):325-34. PubMed ID: 8735634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K
    Urena ES; Diezel CC; Serna M; Hala'ufia G; Majuta L; Barber KR; Vanderah TW; Riegel AC
    Addict Biol; 2024 Aug; 29(8):e13428. PubMed ID: 39087789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
    Main MJ; Cryan JE; Dupere JR; Cox B; Clare JJ; Burbidge SA
    Mol Pharmacol; 2000 Aug; 58(2):253-62. PubMed ID: 10908292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional haemodynamic responses to adenosine receptor activation vary across time following lipopolysaccharide treatment in conscious rats.
    Jolly L; March JE; Kemp PA; Bennett T; Gardiner SM
    Br J Pharmacol; 2008 Aug; 154(8):1600-10. PubMed ID: 18500354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain.
    Zhang F; Liu S; Jin L; Tang L; Zhao X; Yang T; Wang Y; Huo B; Liu R; Li H
    Pharmacology; 2020; 105(7-8):471-476. PubMed ID: 32062659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.
    Hansen HH; Andreasen JT; Weikop P; Mirza N; Scheel-Krüger J; Mikkelsen JD
    Eur J Pharmacol; 2007 Sep; 570(1-3):77-88. PubMed ID: 17628530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, retigabine, reduces capsaicin-induced visceral pain in mice.
    Hirano K; Kuratani K; Fujiyoshi M; Tashiro N; Hayashi E; Kinoshita M
    Neurosci Lett; 2007 Feb; 413(2):159-62. PubMed ID: 17184917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers.
    Xiong Q; Sun H; Zhang Y; Nan F; Li M
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3128-33. PubMed ID: 18272489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
    Wickenden AD; Yu W; Zou A; Jegla T; Wagoner PK
    Mol Pharmacol; 2000 Sep; 58(3):591-600. PubMed ID: 10953053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of myotonia congenita with retigabine in mice.
    Dupont C; Denman KS; Hawash AA; Voss AA; Rich MM
    Exp Neurol; 2019 May; 315():52-59. PubMed ID: 30738808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption.
    McGuier NS; Griffin WC; Gass JT; Padula AE; Chesler EJ; Mulholland PJ
    Addict Biol; 2016 Nov; 21(6):1097-1112. PubMed ID: 26104325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
    Ho WS; Gardiner SM
    Br J Pharmacol; 2009 Jan; 156(1):94-104. PubMed ID: 19133994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anticonvulsant retigabine is a subtype selective modulator of GABAA receptors.
    Treven M; Koenig X; Assadpour E; Gantumur E; Meyer C; Hilber K; Boehm S; Kubista H
    Epilepsia; 2015 Apr; 56(4):647-57. PubMed ID: 25779225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional haemodynamic effects of carbachol injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.
    Bachelard H; Gardiner SM; Kemp PA; Bennett T
    Neuropharmacology; 1994 Jun; 33(6):769-88. PubMed ID: 7936115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of M-current modulation on mammalian vestibular responses to transient head motion.
    Lee C; Holt JC; Jones TA
    J Neurophysiol; 2017 Dec; 118(6):2991-3006. PubMed ID: 28855291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.